New therapeutic key for cystic fibrosis: a role for lipoxins.
- 1 April 2004
- journal article
- editorial
- Published by Springer Nature in Nature Immunology
- Vol. 5 (4) , 357-358
- https://doi.org/10.1038/ni0404-357
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airwayNature Immunology, 2004
- Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Role of airway surface liquid and submucosal glands in cystic fibrosis lung diseaseAmerican Journal of Physiology-Cell Physiology, 2003
- ResolvinsThe Journal of Experimental Medicine, 2002
- A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosisNature Medicine, 2002
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Arachidonic Acid Cascade and Signal TransductionJournal of Neurochemistry, 1990
- Endothelin-1 stimulates arachidonate 15-lipoxygenase activity and oxygen radical formation in the rat distal lungBiochemical and Biophysical Research Communications, 1990
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987